Metal-organic framework molecules with pyrene group-containing or biphenyl group-containing linkers for use in the removal of uremic toxins from biological samples that contain such toxins are provided. Also provided are methods for using the MOFs to remove uremic toxins from biological samples. The methods include hemodialysis of blood samples from patients suffering from a uremia-related disease, such as chronic kidney failure.

A porous polymer aerogel, wherein the aerogel has greater than 5 wt % of amine containing vinyl monomers integrated into a polymer backbone. A method of fabrication of a porous polymer aerogel amine material, includes preparing a solution comprising at least a solvent, amine monomers having protected amino groups, one or more crosslinkers, one or more radical initiators, and a nitroxide mediator, removing oxygen from the solution, heating the solution to promote polymerization and to produce a polymerized material, performing solvent exchange with the polymerized material, causing a deprotection reaction in the polymerized material to remove groups protecting the amino groups, soaking and rinsing the material to remove excess reagents and any byproducts of the deprotection reaction, and drying the material to produce the amine sorbent. A system to separate CO2 from other gases, comprising a polymer porous aerogel sorbent having greater than 5 wt % of amine containing vinyl monomers integrated into a polymer backbone.

A method for manufacturing a membrane, which includes at least the following steps of: preparing a mixture that contains at least an aqueous solution of a cationic polymer whose pH is between 5 and 8, the cationic polymer having positively-charged groups in this aqueous solution, and an aqueous solution of an anionic polymer, the anionic polymer having negatively-charged groups in this aqueous solution; stirring the mixture; leaving the mixture to mature to cause the ionic interaction between positively-charged groups of the cationic polymer and negatively-charged groups of the anionic polymer, until obtaining within the mixture a membrane in the form of a hydrogel; adding at least one crosslinking agent so as to crosslink the membrane; drying the crosslinked membrane obtained upon completion of the previous step. This membrane is used for the treatment of liquid or gaseous effluents, as well as an antimicrobial support or for heterogeneous catalysis.

Provided are a gas treatment method and a gas treatment device capable of efficiently removing a bromofluoroethylene. A gas containing a bromofluoroethylene is brought into contact with an adsorbent (7) having pores with an average pore diameter of 0.4 nm or more and 4 nm or less in a temperature environment of not less than 0° C. and less than 120° C. to allow the adsorbent (7) to adsorb the bromofluoroethylene, and thus the bromofluoroethylene is separated from the gas.

A mesoporous organic material which makes it possible to extract, using the liquid-solid extraction technique, the uranium(VI) contained in an aqueous medium including phosphoric acid, with high efficiency and high selectivity for the iron that the medium can likewise contain. The material is likely to be obtained by cross-linking polymerisation of a monomer of formula (I) below, wherein: R.sup.1, R.sup.2 and R.sup.3 are, independently from one another, H, a C.sub.1 to C.sub.12 saturated or unsaturated, linear or branched hydrocarbon group, or a polymerisable group, with the condition that at least one of R.sup.1, R.sup.2 and R.sup.3 is a polymerisable group; R.sup.4 and R.sup.5 are, independently from one another, H or a C.sub.1 to C.sub.8 saturated or unsaturated, linear or branched hydrocarbon group; the cross-linking polymerisation being carried out in the presence of a cross-linking agent and one or more pore-forming agents.

The invention is directed to ion capture devices and methods for ion capture.

Embodiments of a method of purifying a lysophosphatidylcholine (e.g., LPC-DHA and/or LPC-EPA) from a composition containing the lysophosphatidylcholine and at least one impurity, e.g., from phospholipids, free fatty acids, triacylglycerols (TAGs), diacylglycerols (DAGs), monoacylglycerols (MAGs), glycerol, sterols, tocopherols, vitamin A, flavonoids, and minerals can use a continuous simulated moving bed process, a batch column chromatography method, or a single column to provide a purified composition of the lysophosphatidylcholine. The purified lysophosphatidylcholine (e.g., LPC-DHA and/or LPC-EPA) products can be used in various pharmaceutical and nutraceutical applications, e.g., for treating and/or preventing a neurological disease or disorder.

The present invention aims to provide a material for adsorbing soluble tumor necrosis factor receptors with high efficiency. The present invention provides an adsorbing material for soluble tumor necrosis factor receptors, which includes a superficially porous water-insoluble polymeric material, wherein the pore size distribution curve for the surface of the water-insoluble polymeric material, which is derived from a distribution of melting points determined by differential scanning calorimeter, shows the peak radius in the range of 1 to 80 nm, and the water-insoluble polymeric material has a zeta potential at pH 7.4 of −15 to 15 mV, and the water-insoluble polymeric material is in fiber, particle, or film form.

An adsorbent and a granulated substance for which reduction in adsorption performance in low humidity environments is suppressed are provided. The adsorbent includes: a porous body mainly composed of silicon dioxide, including a plurality of fine pores, and having a specific surface area of not less than 1 m.sup.2/g and not more than 10 m.sup.2/g; one of an acid and a base with which inside of the fine pores of the porous body is impregnated to neutralize a target gas to generate a salt; and a hydrophilic fiber held in the porous body.

The present invention relates to an activated carbon, having a pore volume (A) of 0.3 to 0.7 mL/g at a pore diameter of 6.5 to 50 nm as determined by mercury intrusion porosimetry, a pore volume (B) of 0.23 mL/g or less at a pore diameter of 750 to 4,000 nm as determined by mercury intrusion porosimetry, and a pore volume ratio (A)/(B) of 1.7 or higher.